Overview of Dr. Nauseef
Dr. Jones Nauseef is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and New York-Presbyterian Hospital. He received his medical degree from University of Iowa Roy J. and Lucille A. Carver College of Medicine and has been in practice 7 years. He is one of 370 doctors at New York-Presbyterian Hospital and one of 370 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 20 publications and over 500 citings.
Office
505 E 70th St
New York, NY 10021Fax+1 212-746-4610
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2015 - 2018
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2015
Certifications & Licensure
NY State Medical License 2018 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A multi-perspective study assessing Black and African American participation barriers in prostate cancer clinical trials.Paul Leger, Stanley Frencher Jr, Jones T Nauseef, Brian Jones, Mehmet A Bilen
Future Oncology. 2025-04-01 - Baseline Imaging Derived Factors of Response Following [225Ac]Ac-J591 Therapy in Metastatic Castration-Resistant Prostate Cancer: A Lesion Level Analysis.Judith Stangl-Kremser, Andres Ricaurte-Fajardo, Sandra Huicochea Castellanos, Alexander Martinez-Fundichely, Michael Sun
The Prostate. 2025-04-01 - Mesonephric Adenocarcinoma in a Young Male Patient.Daniela Guevara, Nara Shin, Alexandra Boiko, Ivan Valiev, Ahmed G Elsaeed
Anticancer Research. 2025-02-01
Press Mentions
Robust PSA Drops with Radionuclide Therapy in Castration-Resistant Prostate CancerApril 18th, 2023- ASCO GU 2021: Prevalence of Microsatellite Instability and Monitoring Response to Immune Checkpoint Inhibition Utilizing Liquid Biopsy Among African American Men with Advanced Prostate CancerFebruary 12th, 2021
- ASCO GU 2021: Multi-Institutional Evaluation of the Clinical Outcomes and Genomic Correlates of African Americans with Metastatic Castration-Sensitive Prostate CancerFebruary 11th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
